Why so many doses, and why now?
作者信息
Bilgic S, Akovalı B
出版信息
Eur Thyroid J. 2025 Jun 9;14(3). doi: 10.1530/ETJ-25-0115. Print 2025 Jun 1.
Abstract
摘要
相似文献
1
Why so many doses, and why now?为什么要有这么多剂量，而且为什么是现在？
Eur Thyroid J. 2025 Jun 9;14(3). doi: 10.1530/ETJ-25-0115. Print 2025 Jun 1.
2
Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer.氨磷汀用于大剂量放射性碘治疗分化型甲状腺癌时的唾液腺保护
Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD007956. doi: 10.1002/14651858.CD007956.pub2.
3
Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases.放射性碘治疗分化型甲状腺癌伴甲状腺球蛋白阳性及放射性碘阴性转移灶
Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD006988. doi: 10.1002/14651858.CD006988.pub2.
4
Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial.研究 Selumetinib 使晚期碘难治性分化型甲状腺癌对放射性碘治疗重新敏感的潜在临床获益（SEL-I-METRY）：一项多中心英国单臂 II 期试验的方案。
BMC Cancer. 2019 Jun 14;19(1):582. doi: 10.1186/s12885-019-5541-4.
5
Pediatric differentiated thyroid carcinoma leading to fatal lung fibrosis.导致致命性肺纤维化的小儿分化型甲状腺癌
Eur Thyroid J. 2025 Feb 24;14(1). doi: 10.1530/ETJ-24-0341. Print 2025 Feb 1.
7
Whole-remnant and maximum-voxel SPECT/CT dosimetry in I-NaI treatments of differentiated thyroid cancer.分化型甲状腺癌碘-碘化钠治疗中全残留和最大体素SPECT/CT剂量测定法
Med Phys. 2016 Oct;43(10):5279-5287. doi: 10.1118/1.4961742.
8
Dosimetry and thyroid cancer: the individual dosage of radioiodine.剂量学与甲状腺癌：放射性碘的个体剂量。
Endocr Relat Cancer. 2010 Jun 3;17(3):R161-72. doi: 10.1677/ERC-10-0071. Print 2010 Sep.
9
Individualized dosimetry in children and young adults with differentiated thyroid cancer undergoing iodine-131 therapy.接受碘-131治疗的分化型甲状腺癌儿童和青年患者的个体化剂量测定
J Pediatr Endocrinol Metab. 2020 Jul 13. doi: 10.1515/jpem-2020-0072.
10
Radioactive Iodine in Differentiated Thyroid Carcinoma: A Systematic AGREE II Clinical Practice Guideline Appraisal.放射性碘在分化型甲状腺癌中的应用：一项系统评价 AGREE II 临床实践指南。
Otolaryngol Head Neck Surg. 2024 Jan;170(1):20-33. doi: 10.1002/ohn.508. Epub 2023 Sep 11.
引用本文的文献
1
Response to letter: 'why so many doses, and why now?'.对信件的回复：“为何有这么多剂量，又为何是现在？”
Eur Thyroid J. 2025 Jun 12;14(3). doi: 10.1530/ETJ-25-0155. Print 2025 Jun 1.
本文引用的文献
1
Pediatric differentiated thyroid carcinoma leading to fatal lung fibrosis.导致致命性肺纤维化的小儿分化型甲状腺癌
Eur Thyroid J. 2025 Feb 24;14(1). doi: 10.1530/ETJ-24-0341. Print 2025 Feb 1.
2
Radioiodine Therapy in Pediatric Differentiated Thyroid Cancer: Dosimetry, Clinical Care, and Future Challenges.儿童分化型甲状腺癌的放射性碘治疗：剂量测定、临床护理及未来挑战
Clin Nucl Med. 2023 Feb 1;48(2):158-167. doi: 10.1097/RLU.0000000000004431. Epub 2022 Oct 14.
3
Pulmonary fibrosis following radioiodine therapy of pulmonary metastases from differentiated thyroid carcinoma.分化型甲状腺癌肺转移灶放射性碘治疗后发生的肺纤维化。
Thyroid. 2010 Mar;20(3):337-40. doi: 10.1089/thy.2009.0266.
Zotero 插件